To amend the Federal Food, Drug, and Cosmetic Act to require the holders of approved applications for drugs to conduct a risk assessment to identify and evaluate risks to their supply chain and develop, maintain, and implement risk mitigation plans to address such risks, and for other purposes.
Limit Ongoing Shortages and Stabilize Supply Act of 2020 or the LOSS Act of 2020
This bill addresses drug shortages, including by requiring drug manufacturers to conduct risk assessments and implement risk-mitigation plans with respect to such shortages.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line